Latest News and Press Releases
Want to stay updated on the latest news?
-
BRISBANE, Calif., Dec. 12, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Sept. 23, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
BRISBANE, Calif., Sept. 02, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
-
Another crucial milestone in the KaloBios transformationShifts all focus and resources to near-term incremental value catalysts BRISBANE, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) --...
-
Provides mechanism for reduction of Mr. Shkreli’s ownership under certain circumstancesImmediately protects company by restricting his rights, actions as shareholder BRISBANE, Calif., July 07,...